Briumvi Approved for Relapsing Forms of Multiple Sclerosis
The FDA has approved Briumvi™ (ublituximab-xiiy) for the treatment of relapsing forms of multiple sclerosis in adults.
Stay updated with breaking news from Neurological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has approved Briumvi™ (ublituximab-xiiy) for the treatment of relapsing forms of multiple sclerosis in adults.
TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy) - read this article along with other careers information, tips and advice on BioSpace
BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms of multiple sclerosis that can be administered in a...
While some may have objected to Stevens' crushing blows, his take at the time was that "hitting is part of the game."
A new study provides more reassurance that in utero exposure to antiseizure medications are safe and do not have a negative effect on children's cognition.